Overview

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
Illuccix will be used per the prescribing instructions for PET-CT imaging on the United Imaging scanner uEXPLORER to establish a standard scanning protocol.
Phase:
Early Phase 1
Details
Lead Sponsor:
BAMF Health
Collaborator:
Telix International Pty Ltd
Treatments:
Gallium 68 PSMA-11